PharVision Advisers’s Diodes DIOD Stock Holding History

PharVision Advisers’s Portfolio DIOD Stock Details DIOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,548	Closed	-$242K	–	758
2025 Q3	$242K	Buy	+4,548	New	+$244K	0.14%	356

Other funds holding DIOD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PharVision Advisers's DIOD Position: Q4 2025 in Review

PharVision Advisers sold out of Diodes (DIOD) in Q4 2025, closing a stake of 4,548 shares — an estimated $242K sold.

PharVision Advisers first reported a position in DIOD in Q3 2025 and held it in 1 quarter. The position peaked at $242K in Q3 2025. 303 funds tracked by Wall St. Rank hold DIOD as of Q4 2025.

PharVision Advisers reported no remaining Diodes position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 4,548 Diodes shares in Q4 2025, an estimated $242K.
PharVision Advisers first reported a position in Diodes in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Diodes position peaked at $242K in Q3 2025.
303 funds tracked by Wall St. Rank held Diodes as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.